Regulation of Tau Homeostasis by Molecular Chaperones

About the Research Project
Program
Award Type
Standard
Award Amount
$250,000
Active Dates
July 01, 2015 - June 30, 2018
Grant ID
A2015297S
Summary
Alzheimer’s disease is a devastating condition that impacts patients, their families and their caregivers. There are no treatments for this disease, so a major goal of our group is to pursue new and unconventional ways of preventing it. In the current proposal, we are trying to understand how the body’s own proteins (termed molecular chaperones) protect us against Alzheimer’s disease. At the same time, we hope to learn why this system fails during disease, so we can use this knowledge to design drugs that activate the molecular chaperones.
Grants
Related Grants
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD